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Abstract
Rationale Previous studies have shown that blockade of
metabotropic glutamate 5 receptors (mGluR5) results in
inhibition of nicotine self-administration in experimental
animals. However, these studies have not established the
behavioural mechanisms which mediate these effects or the
extent to which the effects of mGluR5 antagonism on
nicotine self-administration reflect a selective attenuation of
nicotine reinforcement.
Objectives To investigate the effects of antagonising
mGluR5 receptors on psychopharmacological responses to
nicotine measured using conditioned and unconditioned
behaviours.
Results 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) signif-
icantly (P<0.01) reduced nicotine self-administration and
attenuated (P<0.01) the ability of non-contingent nicotine to
enhance the reinforcing properties of a weak reinforcer
(extinguishing the house light in an operant chamber). It also
attenuated (P<0.05) the much lower levels of responding for
this reinforcer measured in control animals treated with
saline. MPEP did not attenuate the increase in locomotor
activity induced by acute and repeated nicotine in animals
habituated on the test day to the test environment.
Furthermore, it had no significant effects on responding for
a palatable food reward. By contrast, MPEP significantly
reduced (P<0.001) conditioned locomotor stimulation
evoked by pairing nicotine with a specific environment.
Conclusion The results are consistent with the hypothesis
that mGluR5 receptors play an important role in mediating
the effects of contextual cues in conditioned behavioural
responses to nicotine.
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Introduction
It is now widely accepted that nicotine has the properties of
a drug of dependence and that it is the major addictive
component of tobacco smoke (Henningfield et al. 2009;
Benowitz 2009). Surprisingly, however, in intravenous self-
administration studies with rodents, nicotine is a relatively
weak reinforcer when it is administered alone, and these
weak reinforcing properties do not seem to provide an
adequate explanation for the powerful addiction to tobacco
experienced by many habitual smokers (Caggiula et al.
2001; Balfour 2006). However, the acquisition of nicotine
self-administration is enhanced significantly if a stimulus,
such as a tone and/or a light, is associated with the delivery
of each nicotine infusion (Caggiula et al. 2001; Cohen et al.
2005). By association with nicotine, the stimulus acquires
the properties of a conditioned stimulus which is sufficient-
ly reinforcing to maintain nicotine-seeking behaviour in the
absence of nicotine for an extended period of time
(Caggiula et al. 2001; Chaudhri et al. 2006a; Cohen et al.
2005). Additionally, nicotine has the ability to enhance the
reinforcing properties of stimuli which are, when delivered
alone, only weakly reinforcing, and it has been suggested
that this property of the drug also plays a significant role in
the psychobiology underpinning addiction to the drug
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2006). Thus, these data support the hypothesis that
dependence upon tobacco may reflect an interaction
between nicotine and stimuli associated with its availability
and delivery.
The neurobiological mechanisms which mediate con-
ditioned responding to nicotine have been the subject of
relatively few studies. However, experiments with other
psychostimulant drugs have implicated glutamatergic
systems in drug-seeking behaviour evoked by condi-
tioned stimuli (Burns et al. 1994;Y o ue ta l .2007;
Crombag et al. 2008). Furthermore, there is a growing
body of evidence that the role of glutamate in conditioned
responding may depend to a significant degree upon the
stimulation of mGluR5 receptors (Martin-Fardon et al.
2009; Bäckström and Hyytiä 2007). There is also evidence
that mGluR5 receptors play a role in nicotine self-
administration and in the cue-induced reinstatement of
nicotine-seeking behaviour (Paterson et al. 2003;T e s s a r i
et al. 2004; Palmatier et al. 2007). The role of mGluR5
receptors in the more complex mechanisms thought to
underpin nicotine dependence is less clear. In this study
therefore, the non-competitive mGluR5 receptor antagonist
2-methyl-6-(phenylethynyl)-pyridine (MPEP) has been ex-
amined for its effects on both contingent and non-contingent
behavioural responses to nicotine. The primary aim of the
study was to explore the extent to which mGluR5 receptors
may be implicated in the role of environmental and
contextual cues in conditioned responding to nicotine.
Materials and methods
Animals
The experiments were performed using male Sprague–
Dawley rats (Harlan UK). The rats weighed approximately
250–270 g at the beginning of each experiment and were
housed in a temperature- and humidity-controlled vivarium
(21°C; 55% humidity), in which the lights were on between
06:00 and 18:00 h daily. For the self-administration studies,
the animals were housed singly. For the other studies, the
rats were house in groups of four. For all the operant
studies, food (standard laboratory chow) was restricted to
20 g per day, a protocol which maintained the rat weights at
approximately 90% of free-feeding weight. All the experi-
ments were performed under the auspices of UK Home
Office licence PPL 60/1375.
Nicotine intravenous self-administration studies
The rats (n=21) were trained in 1-h sessions to lever press
(for half the rats, the left lever was active; for the
remainder, the right lever was active) in standard two-
lever operant chambers (MED Associate Inc.) on a fixed
ratio 1 with a 20 s timeout (FR1:TO20) schedule for a 45-
mg sucrose pellet reinforcer. The house light was on
during the session. During the timeout period, active lever
pressing was recorded but did not have any programmed
consequences. When the responding was stable (for three
consecutive sessions, the variability of the number of
responses on the active lever was less than 20%, and
stable intake of food was reached), rats were transferred to
the FR3:TO20 schedule of reinforcement and stable-
responding re-established.
After acquiring the operant behaviour, rats were anaes-
thetised with 5% isofluorene in 2% of oxygen and
implanted with chronic silastic catheters (Camcaths, Cam-
bridge UK) in the jugular vein. Carprofen (Pfizer; 5 mg/
kg, s.c.) was used as the analgesic during the surgery. For
the 6 days following surgery, the animals were given
Timentin (GSK; 60 mg, i.v. in 100 μl) prophylactically,
and the catheters were flushed daily with heparin (3 U in
0.1 ml) daily. The animals were given 7–10 days to
recover from the surgery before commencing with nicotine
self-administration. During nicotine self-administration,
the catheters were flushed with heparin before and after
each session.
Intravenous nicotine self-administration (IVSA) was
under an FR3:TO20 schedule of reinforcement. The active
lever previously associated with food delivery was paired
with the delivery of nicotine (0.03 mg/kg/infusion) deliv-
ered in a volume of 60 µl in 3.2 s. Responding on the
inactive lever was recorded but did not have any
programmed consequences. The delivery of the nicotine
infusion was paired with a 20-s cue light located above the
active lever and a 1-s tone (Cohen et al. 2005). During the
20-s timeout period, lever pressing on the active lever was
recorded but did not have any programmed consequences.
The session was terminated if a maximum of 30 nicotine
infusions was reached or after 60 min. Once the rats
reached a stability criterion (less than 30% variability for
the number of active press lever over three consecutive
sessions), the effects of MPEP and its vehicle were tested
for their effects on responding for nicotine. In 16 rats, three
different intravenous doses of MPEP 2.5 mg/kg (N=8),
MPEP 5 mg/kg (N=4) and MPEP 10 mg/kg (N=4) and
saline were tested. The drug was always delivered in a
volume of 0.1 ml (equivalent to approximately 0.33 ml/kg).
MPEP 5 and 2.5 mg/kg or its saline vehicle was also
administered (i.p.) using a counter-balanced design in five
additional rats trained to respond for nicotine. Each
injection was separated by 48 h, with a normal 1 h nicotine
self-administration session on the intervening day. MPEP
was administered 30 min before nicotine self-administration
session.
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The protocol was based on that described by Donny et al.
(2003). Rats were initially trained to lever press on the right
or left lever of a two-lever operant chamber for a sweetened
pellet on a continuous schedule of reinforcement. The
training sessions were terminated after 60 min or when the
rats had received 100 reinforcers. The groups of rats were
given s.c. injections of saline (1 ml/kg) or nicotine (0.4 mg/
kg) to habituate them to the injection, 2 h after each of the
last five training sessions. Once responding was stable (the
rats consistently received 100 sucrose pellets in 30 min),
the rats were transferred to an FR1:TO20 schedule of
reinforcement. In this schedule, a correct lever-pressing
response was reinforced by brief illumination (2 s) of a
stimulus light above the active lever and extinguishing the
house light for 20 s. The animals habituated to saline were
given s.c. saline, 5 min prior to each session; those
habituated to nicotine were given s.c. nicotine. Once
responding was stable (the variation in responding was less
than 30% over three consecutive days), the contingency
was increased to FR2:TO20. In one experiment (N=6 per
group), this contingency was maintained for five daily
sessions and then increased to FR5:TO20 for 5 days. In an
experiment with a second group of rats (N=6 per group),
the animals were maintained on the FR2:TO20 schedule
and used to investigate the effects of i.p. MPEP (2.5 and
5.0 mg/kg) and saline on lever pressing using a counter-
balanced design. In a minimum of three operant sessions
intervened between the test days, the animals receiving
their habitual treatment (saline or nicotine) on the interven-
ing days.
Food-reinforced behaviour
The rats were initially trained to respond for a sweetened
food reward in the same operant chambers used for nicotine
self-administration under a FR1:TO20 schedule of rein-
forcement. The schedule was changed to a FR3:TO20s
when rats had acquired the previous schedule. Delivery of
the reinforcer was coupled with the same conditioned
stimulus (stimulus light on for 20 s; tone 1 s) as that used
for the nicotine self-administration studies. Once respond-
ing for food was stable, drug testing was initiated. MPEP
5 mg/kg (i.p.) or its saline vehicle was administered 30 min
before the test session using a counter-balanced design.
Locomotor activity experiments
Twenty-four rats were divided in four groups of six rats
each. On day 1, the effects of MPEP 5 mg/kg on the
locomotor responses to acute nicotine (0.4 mg/kg, s.c.) or
saline were investigated. Each rat was placed in a 4-arm
maze (each arm was 42 cm long×14 cm across with 30 cm
high sides) for 30 min to habituate them to the maze. The
rats were then given i.p. injections of saline or MPEP and
30 min later by nicotine (0.4 mg/kg, s.c.) or saline. Activity
(entries in the arms) was recorded every 10 min throughout
and for 20 min after the s.c. injection. The animals
previously injected with nicotine or saline were respectively
given daily injections of nicotine (nicotine-pretreated) or
saline (saline-pretreated) in their home cage on days 2–8;
on day 9, no treatment were given. On day 10, the effects of
MPEP on the locomotor responses to nicotine (in nicotine-
pretreated rats) or saline (saline-pretreated rats) were again
investigated using a protocol identical to that employed on
day 1.
Conditioned locomotor experiments
Rats were assigned to one of two groups. One group (maze
paired group) was treated with daily s.c. of saline (N=6) or
nicotine (0.4 mg/kg; N=6) for 16 days, and 5 min after each
injection, they were placed in the four-arm cross maze for
15 min. Activity (arm entries) was recorded on days 1, 5,
10, and 15. A second group of rats (maze unpaired group)
were also treated with s.c. saline (N=6) or nicotine (0.4 mg/
kg; N=6) for 16 days but were returned to their home cages
after each injection. On days 17 and 21, the rats were
pretreated with saline or MPEP (5 mg/kg) using a counter-
balanced design 30 min prior to an injection of saline, and
the activity was tested for 15 min starting 5 min after the
second injection. On the intervening days, the animals
received their habitual injections of saline or nicotine and
were placed in the maze as usual or were returned to their
home cages. On days 26 and 30, the effects of pretreating
the animals with MPEP or saline were also investigated in
rats which received their habitual injection of nicotine
5 min prior to testing in the maze.
Drugs
(−)-Nicotine hydrogen tartrate (Sigma Aldrich) was dis-
solved in saline and neutralised with 0.1 N NaOH. Non-
contingent injections of the drug were delivered in volume
of 1 ml/kg. The doses are expressed in terms of the free
base. MPEP (Sigma Aldrich) was also dissolved in saline.
Intravenous injections were given in a volume of 0.1 ml.
Intraperitoneal injections were delivered in a volume of
1 ml/kg.
Data analysis
All results are reported as means ± SEM. For the IVSA
experiment, the data were analysed using an ANOVA for
repeated measures with treatment on the test day and active
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variable. Post hoc analyses were performed using paired
t tests. For the other operant studies, a two-way ANOVA
for repeated measures was used using habitual treatment as
the between-subject variable with pretreatment on the test
day and active versus inactive lever responses as the within-
subject variables. Post hoc analyses were performed using
paired t tests. In the first response-enhancing study, contin-
gency was used as an additional within-subject variable.
The data derived from the locomotor studies using the cross
maze were also analysed using a two-way ANOVA with
habitual treatment (saline or nicotine) and test treatment as
the between-subject factors and days of treatment as the
within-subject variable. In the studies on conditioned loco-
motor responding, two-way ANOVA for repeated measures
was also employed. Habitual treatment (saline or nicotine)
and habituation/no habituation to the maze were the
between-subject factors analysed; pretreatment on the test
day was the within-subject factor.
Results
Operant experiments
Using the paradigm adopted for this study, rats consistently
pressed on the active lever for nicotine at a rate which was
significantly higher (F(1,8)=47.76, P<0.001) than respond-
ing on the inactive lever (Fig. 1). On the test days,
responding for nicotine was influenced by the treatment
the animals received (treatment × lever F(3,24)=31.98, P<
0.001). Post hoc analysis showed that treatment with MPEP
(2.5 or 5.0 mg/kg) reduced responding on both the active
lever (treatment F(1,8)=80.57, P<0.001) and the inactive
lever (treatment F(1,8)=8.43, P<0.05) when compared
with the day on which the animals were given saline. The
data suggest that the effects of MPEP were dose-dependent,
although statistically, the response was not influenced by
the dose of MPEP employed. The treatment on the test day
had no significant effect on the performance of the rats on
the day following treatment which returned to baseline
levels. An intravenous injection of MPEP at a dose of
10 mg/kg resulted in complete inhibition of responding for
nicotine in all of the rats tested.
The i.p. administration of MPEP (2.5 mg/kg) also
attenuated responding for nicotine (treatment × lever F
(3,12)=17.62, P<0.01). Post hoc analysis showed again
that pretreatment with MPEP inhibited responding on both
the active lever (F(3,12)=0.87, P<0.001) and inactive lever
(F(3,12)=9.99, P<0.001). Pretreatment with MPEP (5 mg/
kg, i.p.) resulted in total inhibition of responding in all of
the five rats tested. By contrast, 5 mg/kg MPEP had no
significant effects on responding on the active lever for a
palatable food reward (active lever presses after i.p. saline=
209±35; active lever presses after i.p. MPEP=183±35).
The response-enhancing effects of subcutaneous nicotine
were investigated using a protocol in which rats were
trained to extinguish the house light. The pilot study
showed that rats trained in this protocol preferentially
pressed the active lever (lever F(1,10)=65.1, P<0.001;
Fig. 2). Responding was significantly enhanced in nicotine-
treated animals in a manner which was dependent upon the
contingency (nicotine × contingency F(2,20)=5.4, P<
0.05). Furthermore, nicotine preferentially enhanced res-
ponding on the active lever (lever × nicotine F(1,10)=9.81,
P<0.05). Post hoc analysis revealed a significant effect of
nicotine on active lever responding in rats tested on the FR2
or FR5 schedules (F(1,10)=17.23, P<0.01 and 7.53, P<
0.05, respectively). Nicotine also significantly enhanced
responding on the inactive lever under the FR5 condition (F
(1,10)=6.65, P<0.05). The effects of MPEP were investi-
gated in a second group of rats stably maintained on the
FR2 schedule of reinforcement (Fig. 3). These experiments
confirmed that nicotine preferentially enhanced responding
on the active lever (lever × nicotine F(1,10)=34.57, P<
0.001; post hoc analysis P<0.001), although it also
increased responding on the inactive lever (P<0.05).
Pretreatment with MPEP on the test day dose-dependently
reduced responding on both levers in the saline- and
nicotine-treated rats (F(2,20)=37.1, P<0.001 for the active
lever; F(2,20)=5.3, P<0.05 for the inactive lever; Fig. 3).
The effect of the MPEP injections in nicotine-treated rats on
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Fig. 1 The effects of intravenous MPEP on operant responding for
nicotine. Rats were trained to lever-press for nicotine on an FR3
schedule of reinforcement with a 20-s timeout. The figure shows mean
responding on the active lever (open columns) and the inactive lever
(filled columns) for rats pretreated with saline or MPEP (N=8 for
2.5 mg/kg; N=4 for 5.0 mg/kg) prior to the session. Data for the day
after the MPEP session are also presented. The data are reported as
means ± SEM. Significantly different from rats pretreated with saline
*P<0.05; **P<0.01
36 Psychopharmacology (2010) 211:33–42responding on the active lever was more highly significant
than that measured in the saline-treated rats (nicotine ×
MPEP F(2,20)=10.3, P<0.001). The difference in the
effects of MPEP on responding on the inactive lever
between the saline- and nicotine-treated rats approached
significance (F(2,20)=3.0, P=0.073). Following comple-
tion of the experiments with MPEP, the lever which
extinguished the light was switched from the one used
during training to the lever on the opposite side of the box.
Over a period of 14 days, responding on the active lever
used during training decreased (F(1,10)=23.7, P<0.001),
whereas responding on the lever which was inactive during
training increased (F(1,10)=39.7, P<0.001; Fig. 4). In both
cases, the effect was statistically more significant for the
nicotine-treated rats (nicotine × days F(1,10)=6.3, P<0.05
for active to inactive; F(1,10)=24.7, P<0.001 for inactive
to active).
Studies employing the cross maze
When exploration of the cross maze was investigated in rats
which were allowed to habituate to the apparatus for 60 min
(Fig. 5), the activity of the saline-treated rats was very low
(mean<5 entries in 20 min). When nicotine was tested for
its effects on maze exploration in these rats, both acute and
repeated administration of the drug increased entries into
the arms of the maze (nicotine F(1,20)=80.54, P<0.001;
Fig. 5). The response to nicotine was also influenced by
pretreatment with the drug (nicotine × days F(1,20)=5.60,
P<0.05). Post hoc analysis showed that the stimulant
response to nicotine was greater (P<0.05) in the animals
pretreated with the drug for 8 days prior to the test session.
The responses to both acute and repeated nicotine were not
influenced significantly by prior treatment with MPEP on
the test day.
The final experiment explored the effects of nicotine and
MPEP on initial activity in the cross maze measured during
15 min after the animals were placed in the maze. The
activity of the rats, which were repetitively tested in the
maze, was influenced significantly (treatment × sessions F
(3,30)=12.99, P<0.001) by both treatment and the duration
of treatment (Fig. 6). Post hoc analysis showed that nicotine
reduced activity on day 1 (P<0.001) from 33.0±1.9 to 15.8
±1.6 entries per 15 min, whereas by day 15, the activity of
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Fig. 2 The influence of contingency on the response-enhancing
effects of nicotine. Groups of rats (N=8 in each group) were treated
with daily injections of saline (open bars) or nicotine (0.4 mg/kg, s.c.;
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Fig. 3 The effects of MPEP on
the response-enhancing effects
of nicotine. Saline and nicotine
(0.4 mg/kg, s.c.) treated rats
(N=8 in each group) were
trained in an operant task (FR2:
TO20) reinforced by a stimulus
light above the active lever and
extinguishing the house light.
The bars represent means ±
SEM for the lever-pressing
responses on the active lever
(panel A) and the inactive lever
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Psychopharmacology (2010) 211:33–42 37the nicotine-treated rats was significantly increased (P<
0.05) from 27.8±4.3 to 41.5±2.3 entries per 15 min when
compared with the saline-treated control animals. In the
animals which had been repeatedly injected with saline or
nicotine, there was a significant interaction between the
effects of nicotine treatment on activity and prior experi-
ence of the maze (nicotine × habituation F(1,20)=5.8, P<
0.05). Post hoc analysis revealed that repeated nicotine
administration did not enhance the higher levels of
locomotor activity measured in animals which had not
been habituated to the apparatus by prior repeated exposure
to the apparatus (Fig. 7). Furthermore, pretreatment with
MPEP had no significant effects on the locomotor activity
of either saline-treated or nicotine-treated rats tested in this
way. By contrast, in the animals repeatedly exposed to the
maze after each injection, nicotine stimulated activity (P<
0.01). In these animals, the effects of MPEP depended upon
treatment during the habituation phase of the experiment
(nicotine × MPEP F(1,10)=6.5, P<0.05). Post hoc analysis
showed that MPEP inhibited the activity of rats treated with
nicotine (MPEP F(2,10)=14.79, P<0.001) but had no
significant effects in the rats treated with saline. If the rats
were habituated to the maze and were then tested in the
maze following an injection of saline, there was a
significant interaction between the effects of prior exposure
to the maze and the treatment administered during the
conditioning phase (nicotine × habituation F(1,20)=12.5,
P<0.01). In rats conditioned to the maze with nicotine, the
number of entries made when they were subsequently
tested after an injection of saline remained significantly
higher (P<0.01) than that recorded for animals conditioned
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Fig. 6 The effects of repeated nicotine on activity in a cross maze.
Groups of rats (N=6 per group) were given daily s.c. injections of
saline (open circles) or nicotine (0.4 mg/kg; filled triangles) and
placed in the maze after each injection for 15 min. The results are
expressed as mean ± SEM and represent the data for the days on
which activity was recorded. Significantly different from saline-treated
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38 Psychopharmacology (2010) 211:33–42to the maze with saline injections. This was not true for
animals not habituated to the maze after each injection of
nicotine. Moreover, for the rats treated with saline on the
test day, there was a significant three-way interaction
between the effects of MPEP on entries, habituation to the
maze and the treatment the animals received during
habituation (MPEP × nicotine × habituation F(1,20)=6.0,
P<0.05). Post hoc analysis showed that MPEP reduced
activity in the rats which had been habituated to the maze
with nicotine (MPEP × nicotine F(1,10)=8.9, P<0.05) but
had no significant effects in rats which had been treated
habitually with saline or rats which had been repeatedly
treated with nicotine but not habituated to the maze after
each injection.
Discussion
The initial results presented in this paper have confirmed
those of previous studies (Paterson et al. 2003; Tessari et al.
2004; Palmatier et al. 2007) which have shown that the
administration of mGluR5 receptor antagonists reduces the
intravenous self-administration of nicotine. The present
study has shown that this effect of MPEP seems to be dose-
dependent with the highest dose of MPEP tested, eliciting a
complete inhibition of responding for the drug in many of
the rats. The results imply that responding for nicotine
depends upon the stimulation of mGluR5 receptors within
the brain, although higher doses of the drug also exert other
effects which could be implicated in the psychopharmaco-
logical responses to MPEP. For example, MPEP can inhibit
the neuronal transporter for norepinephrine (Heidbreder et
al. 2003). However, the dose of MPEP used to evoke this
effect in vivo (30 mg/kg, i.p.) was higher than any of the
doses employed in this study. Furthermore, previous studies
which have investigated the effects of MPEP on nicotine
self-administration have employed doses up to 10 mg/kg
and interpreted their findings as evidence for a role of
mGluR5 receptors (Paterson et al. 2003; Tessari et al. 2004;
Palmatier et al. 2007). The effects of MPEP on responding
for nicotine in the IVSA paradigm could have reflected a
general inhibition of the effects of nicotine on behavioural
activity in general since it reduced responding on both
levers. This explanation seems unlikely because MPEP had
no significant effects on the locomotor stimulant properties
of nicotine when measured in an environment to which the
animals which had been extensively habituated on the test
day. Under these conditions, the stimulant response to
nicotine can be observed following both the acute and
repeated administration of the drug. Furthermore, injections
of MPEP did not attenuate responding in animals trained to
lever-press for a palatable food reward, indicating that the
drug does not evoke a generalised reduction in responding
for all reinforcers in this operant procedure. This observa-
tion could reflect a simple difference in efficacy as rewards
of the two reinforcers, the sweetened food reward providing
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Fig. 7 Effects of conditioning on locomotor responses to nicotine in a
cross maze. One group of rats were pretreated with daily injections
(s.c.) of saline or nicotine (0.4 mg/kg) for 16 days (chronic treatment)
and returned to their home cages after each injection (non pre-exposed
rats). On test days, the rats (N=6 per group) were pretreated with
MPEP (5.0 mg/kg, i.p. filled columns) or its saline vehicle (open
columns), using a counter-balanced experimental design, 30 min
before they were given a second s.c. injection (test treatment) of saline
or nicotine. The same experimental design on the test days was used
for a second group of rats which were pre-exposed to the maze by
testing them for 15 min per day after each of their chronic injections.
The data are expressed as means ± SEM. Significantly different from
habituated to the maze with saline **P<0.01. Significantly different
from rats given i.p. saline on the test day ++P<0.01
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However, there are also differences in the neurobiology
underpinning responding for the two reinforcers. Operant
responding for nicotine is attenuated substantially by
lesions of the DA neurones which project to the NAc and
by pharmacological interventions which inhibit the activity
of these neurones (Corrigall et al. 1992, 1994). By contrast,
responding for food rewards is not attenuated significantly
by similar treatments (Salamone et al. 2001). Thus, it seems
equally plausible that the differential effects of MPEP on
responding for the two reinforcers could reflect the
neurobiological substrate through which the compound
exerts its effects on nicotine self-administration.
When compared with other stimulant drugs of depen-
dence, the reinforcing properties of nicotine are relatively
weak and do not appear to provide an adequate explanation
for the powerful addiction to tobacco smoke experienced by
many smokers (Caggiula et al. 2001; Balfour 2006). Thus,
it has been proposed that the powerful reinforcing proper-
ties of tobacco smoke may depend, in part, on the ability of
nicotine to enhance the reinforcing properties of other weak
reinforcers present in the smoke (Rose et al. 2000, 2006;
Donny et al. 2003; Palmatier et al. 2006; Balfour 2004,
2006). Donny et al. (2003) have previously used a yoked
design to show that non-contingent infusions of small doses
of nicotine, delivered throughout the experimental session,
enhance responding for a weak reinforcer. The data
reported in the present study have extended these earlier
findings by showing that a response-enhancing effect, in a
similar paradigm, can also be seen in animals given
nicotine as a single injection prior to the session. It seems
clear that the animals are responding for the reinforcer and
not exhibiting a habitual response on the active lever
because reversing the outcome of pressing the levers also
reverses the lever which is pressed preferentially. The
results have shown that this mode of responding is also
sensitive to antagonism of mGluR5 receptors. However, in
this experiment, the effects of MPEP were not restricted to
the rats trained with nicotine since the compound also dose-
dependently attenuated the lower levels of responding
observed in the saline-treated rats. Thus, a parsimonious
explanation for the data posits that MPEP preferentially
attenuates responding in paradigms and contexts in which
nicotine facilitates responding.
At the higher dose tested, pretreatment with MPEP
abolished responding for nicotine in many of the rats tested
in the IVSA protocol. This observation suggests that the
drug may not only influence nicotine-taking behaviour but
may also inhibit nicotine-seeking behaviour evoked by the
presentation of contextual cues related to the availability of
the drug. This explanation is consistent with the evidence
that environmental and contextual cues repeatedly paired
with the presentation of drugs, including nicotine, are
thought to play a central role in eliciting drug-seeking and
drug-taking behaviour (Spealman et al. 1999; Arroyo et al.
1998; Schenk and Partridge 2001; Caggiula et al. 2002;L e
Foll and Goldberg 2009). It is also consistent with the
results of the experiment reported in the present study in
which the locomotor responses to nicotine were investigat-
ed in animals treated repeatedly with the drug. In experi-
ments performed with animals tested during the first 15 min
of exposure to the cross maze, sensitised responses to
nicotine were only observed in the animals in which the
drug had previously been paired with exposure to the maze.
MPEP had no significant effects on the activity measured in
animals which were unfamiliar with the maze or saline-
treated animals which had been habituated to the apparatus.
By contrast, MPEP inhibited the activity of the nicotine-
treated animals in which the injections had been repeatedly
paired with the maze. The results suggest that MPEP may
preferentially attenuate conditioned responding evoked by
exposure to contextual cues previously paired with nicotine.
The hypothesis is supported further by the evidence that
MPEP also attenuated the conditioned hyperactivity of the
nicotine-pretreated animals when they were tested in the
maze after an injection of saline. It also provides a possible
explanation for the effects of MPEP in the operant studies
in which it attenuated responding on both the active and
inactive levers. This outcome might be predicted if the drug
attenuates the influence of contextual cues on behaviour in
general rather than a selective effect on specific behavioural
responses related to reinforcement.
In summary, this study has confirmed the results of
previous studies which have shown that blockade of
mGluR5 receptors with MPEP attenuates responding for
nicotine in an IVSA paradigm. They have extended these
observations to show that pretreatment with MPEP also
attenuates the response-enhancing effects of nicotine in a
paradigm in which responding is reinforced by a weak
reward. Thus, the data suggest that blockade of the
receptors attenuates the reinforcing properties of nicotine.
However, this simple interpretation may need to be treated
with some caution. The psychopharmacological mecha-
nisms underpinning dependence upon nicotine are complex
and involve interactions between the drug and contextual
stimuli and conditioned reinforcers associated with presen-
tation of the drug which seem to play an especially
important role in nicotine self-administration in rodents
(Caggiula et al. 2002; Chaudhri et al. 2006a, b). The data
presented here suggest that this component of the depen-
dence may be preferentially sensitive to mGluR5 receptor
blockade. If the hypothesis is true, it suggests that
stimulation of mGluR5 receptors may also play a signifi-
cant role in provoking drug-seeking behaviour evoked by
exposure to contextual cues and, putatively, tobacco
cravings in habitual smokers exposed to cues associated
40 Psychopharmacology (2010) 211:33–42with their smoking habit. The data support the conclusion
that antagonists at mGluR5 receptors may prove valuable as
aids to smoking cessation, although this conclusion needs
to be tempered by the evidence that these antagonists may
exacerbate the consequences of nicotine withdrawal
(Liechti and Markou 2007).
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